IGF2BP3 and malignant colon neoplasm: In the future, combination therapies involving traditional chemotherapy drugs and small molecule compounds could be used for drug-resistant colon cancer patients or to enhance therapeutic efficacy, especially in those with high IGF2BP3 expression.